Follow on Google News News By Tag Industry News News By Location Country(s) Industry News
Follow on Google News | Beryllium Initiates New Collaboration with Deciphera PharmaceuticalsBy: Deciphera Pharmaceuticals "Deciphera's collaboration with Beryllium exemplifies our commitment to advancing improved treatment options for patients with cancer," said Daniel Flynn, Ph.D., Chief Scientific Officer at Deciphera Pharmaceuticals. "Beryllium's expertise in structure-directed drug discovery coupled with Deciphera's proprietary switch control kinase inhibitor platform offers the potential to accelerate the delivery of tumor-targeted therapies and immuno-targeted therapies to improve human health." "At Beryllium we are very excited to partner with Deciphera, an industry leading oncology therapeutics company," said Johan Pontin, Chief Executive Officer at Beryllium Discovery. "Deciphera's cutting edge research in kinase inhibitors dovetails with Beryllium's gene to structure expertise and together we will unlock the therapeutic potential of new oncology targets." About Beryllium Using a biology-first, target-centric approach and established platforms, Beryllium provides research services and engages in collaborations with commercial and academic partners. Beryllium's teams of experienced scientists work closely with drug discovery clients to help manage and advance their goals by complementing their capabilities and resources. http://be4.com/ End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|